Boehringer Ingelheim Licenses MetaCore From GeneGo
Complete the form below to unlock access to ALL audio articles.
GeneGo, Inc. has announced that Boehringer Ingelheim has licensed its data mining suite, MetaCore, primarily for toxicogenomics research.
MetaCore is based on a comprehensive, manually curated database of human biology, diseases, toxicology and bioactive chemistry.
"Toxicogenomics is one of the main applications of MetaCore, and we pay a lot of attention to the field in product development," said Julie Bryant, Vice President of Business Development at GeneGo.
"We manually curate all major toxicity journals and develop tools and workflows specifically for the analysis of toxicogenomics datasets; the work is partly sponsored by an NIEHS grant."
"MetaCore was featured in many posters and presentations at the recent Society of Toxicology meeting in San Diego, and is applied by a growing number of toxicogenomics groups in industry and academia."
